Pharmacological management of cancer pain: Novel therapeutics.
Acetaminophen
Antidepressant
Cancer pain
NSAID
Opioids
Pharmacology
Sarcoma
Journal
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
ISSN: 1950-6007
Titre abrégé: Biomed Pharmacother
Pays: France
ID NLM: 8213295
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
28
07
2022
revised:
10
10
2022
accepted:
13
10
2022
pubmed:
23
10
2022
medline:
23
11
2022
entrez:
22
10
2022
Statut:
ppublish
Résumé
Patients diagnosed with cancer often experience pain during their treatment course, making it difficult to care for themselves and continue with their activities of daily living. When cancer is found at later stages, the pain can become severe and constant; reducing their quality of life and significantly affecting mental and physical well-being. Despite opioids being known to provide adequate analgesia for higher pain levels, they are often the reason for under-dosing because of their adverse effects and concern for addiction. There are also patients who do not respond well to opioids because of genetic anomalies or personal preference. Therefore, there is a need for novel non-opioid cancer pain treatments. There are many new cancer pain treatments that are emerging. This manuscript discusses cancer pain, risk factors, epidemiology, guidelines for the treatment of cancer pain, personalization of cancer pain therapy, breakthrough pain, cancer-induced peripheral neuropathy, established cancer pain treatment options, and novel emerging cancer pain treatment options.
Identifiants
pubmed: 36272265
pii: S0753-3322(22)01260-4
doi: 10.1016/j.biopha.2022.113871
pii:
doi:
Substances chimiques
Analgesics, Opioid
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
113871Informations de copyright
Published by Elsevier Masson SAS.